- Home
- GNLX vs MRCC Comparison
GNLX vs MRCC Comparison
Compare GNLX & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- MRCC
- Stock Information
- Founded
- GNLX 2001
- MRCC 2011
- Country
- GNLX United States
- MRCC United States
- Employees
- GNLX N/A
- MRCC N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- GNLX Health Care
- MRCC Finance
- Exchange
- GNLX Nasdaq
- MRCC Nasdaq
- Market Cap
- GNLX 128.0M
- MRCC 151.7M
- IPO Year
- GNLX 2023
- MRCC 2012
- Fundamental
- Price
- GNLX $5.31
- MRCC $7.00
- Analyst Decision
- GNLX Strong Buy
- MRCC Hold
- Analyst Count
- GNLX 4
- MRCC 1
- Target Price
- GNLX $17.75
- MRCC $8.00
- AVG Volume (30 Days)
- GNLX 134.5K
- MRCC 100.3K
- Earning Date
- GNLX 11-13-2025
- MRCC 11-11-2025
- Dividend Yield
- GNLX N/A
- MRCC 14.29%
- EPS Growth
- GNLX N/A
- MRCC N/A
- EPS
- GNLX N/A
- MRCC 0.09
- Revenue
- GNLX N/A
- MRCC $51,229,000.00
- Revenue This Year
- GNLX N/A
- MRCC N/A
- Revenue Next Year
- GNLX N/A
- MRCC N/A
- P/E Ratio
- GNLX N/A
- MRCC $79.24
- Revenue Growth
- GNLX N/A
- MRCC N/A
- 52 Week Low
- GNLX $1.99
- MRCC $5.96
- 52 Week High
- GNLX $5.89
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- GNLX 79.41
- MRCC 40.55
- Support Level
- GNLX $4.17
- MRCC $6.90
- Resistance Level
- GNLX $4.83
- MRCC $7.10
- Average True Range (ATR)
- GNLX 0.29
- MRCC 0.16
- MACD
- GNLX 0.07
- MRCC -0.03
- Stochastic Oscillator
- GNLX 95.62
- MRCC 20.37
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.